232 related articles for article (PubMed ID: 18627649)
21. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial.
Han K; Wang J; Seo JG; Kim H
J Gastroenterol; 2017 Apr; 52(4):432-443. PubMed ID: 27178566
[TBL] [Abstract][Full Text] [Related]
22. The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials.
Niu HL; Xiao JY
Int J Surg; 2020 Mar; 75():116-127. PubMed ID: 32014597
[TBL] [Abstract][Full Text] [Related]
23. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
[TBL] [Abstract][Full Text] [Related]
24. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome.
Hoveyda N; Heneghan C; Mahtani KR; Perera R; Roberts N; Glasziou P
BMC Gastroenterol; 2009 Feb; 9():15. PubMed ID: 19220890
[TBL] [Abstract][Full Text] [Related]
25. The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials.
Wen Y; Li J; Long Q; Yue CC; He B; Tang XG
Int J Surg; 2020 Jul; 79():111-119. PubMed ID: 32387213
[TBL] [Abstract][Full Text] [Related]
26. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Giannetti E; Maglione M; Alessandrella A; Strisciuglio C; De Giovanni D; Campanozzi A; Miele E; Staiano A
J Clin Gastroenterol; 2017 Jan; 51(1):e5-e10. PubMed ID: 27306945
[TBL] [Abstract][Full Text] [Related]
27. Irritable bowel syndrome--diarrhoea.
Wald A
Best Pract Res Clin Gastroenterol; 2012 Oct; 26(5):573-80. PubMed ID: 23384803
[TBL] [Abstract][Full Text] [Related]
28. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
Guglielmetti S; Mora D; Gschwender M; Popp K
Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
[TBL] [Abstract][Full Text] [Related]
29. Irritable bowel syndrome and probiotics: from rationale to clinical use.
Verdu EF; Collins SM
Curr Opin Gastroenterol; 2005 Nov; 21(6):697-701. PubMed ID: 16220048
[TBL] [Abstract][Full Text] [Related]
30. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
31. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
[TBL] [Abstract][Full Text] [Related]
32. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.
Principi N; Cozzali R; Farinelli E; Brusaferro A; Esposito S
J Infect; 2018 Feb; 76(2):111-120. PubMed ID: 29291933
[TBL] [Abstract][Full Text] [Related]
33. Irritable bowel syndrome.
Malone MA
Prim Care; 2011 Sep; 38(3):433-47; viii. PubMed ID: 21872090
[TBL] [Abstract][Full Text] [Related]
34. Irritable bowel syndrome with diarrhea: Treatment is a work in progress.
Kurin M; Cooper G
Cleve Clin J Med; 2020 Jul; 87(8):501-511. PubMed ID: 32737051
[TBL] [Abstract][Full Text] [Related]
35. Review article: probiotics and prebiotics in irritable bowel syndrome.
Spiller R
Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
[TBL] [Abstract][Full Text] [Related]
36. Clinical effects of Lactobacillus strains as probiotics in the treatment of irritable bowel syndrome. Results from the LAPIBSS trial: Future objectives.
Maixent JM; Pons O; Sennoune SR; Sadrin S
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):211-214. PubMed ID: 32538776
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome: A systematic review and meta-analysis.
Asha MZ; Khalil SFH
Sultan Qaboos Univ Med J; 2020 Feb; 20(1):e13-e24. PubMed ID: 32190365
[TBL] [Abstract][Full Text] [Related]
38. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
[TBL] [Abstract][Full Text] [Related]
39. The role of probiotics in management of irritable bowel syndrome.
Borowiec AM; Fedorak RN
Curr Gastroenterol Rep; 2007 Oct; 9(5):393-400. PubMed ID: 17991340
[TBL] [Abstract][Full Text] [Related]
40. [The effects of probiotics on symptoms of irritable bowel syndrome].
Kim YG; Moon JT; Lee KM; Chon NR; Park H
Korean J Gastroenterol; 2006 Jun; 47(6):413-9. PubMed ID: 16809947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
